Origins: Inside Venture Capital

OpenLP from LGT Capital Partners

Details

Hosted by a General Partner (GP) and a Limited Partner (LP), Origins dives into the venture capital ecosystem to learn how the people behind the money make decisions: How LPs choose VC funds to invest in, what drives performance in venture, the dos and don'ts of fundraising, what founders/entrepreneurs/CEOs need to do to raise a Seed, Series A and beyond, what it takes to go from emerging manager to franchise VC, and the latest private market trends and dynamics shaping the investment ecosystem. Origins is co-hosted by GP Nick Chirls and LP Beezer Clarkson.

Recent Episodes

OCT 20, 2026
Carnegie Mellon's Miles Dieffenbach: Can Mega Funds Still Produce Venture Returns?
Miles Dieffenbach's path into venture started with getting cut from the Pittsburgh Steelers. A team captain at Penn State, Miles signed with the Steelers as a priority free agent, played four preseason games, and was released - at 310 pounds, eating 7,000 calories a day, and paying for his own food for the first time in his life. He took the first job he could get, at CBRE, then moved to a real estate private equity firm, his first real look at private markets. When he saw a job posting at the Carnegie Mellon endowment, he didn't know what an endowment did. He applied anyway, got the job, and has been there for close to a decade. Today he is managing director of investments at CMU, where he oversees a roughly $4 billion endowment with close to a quarter allocated to venture - a notably larger share than at many peer institutions. And he has run the math on where the asset class is headed. With fund sizes and the asset base up 10 to 15X over the past 15 years, he expects the beta of venture to be much worse going forward, and past performance to be a far weaker forward indicator than it used to be. Nick and Beezer dig into how CMU underwrites every fund to a 4X net target, benchmarked against a public market equivalent that has compounded at 17 to 18% net since 1998; why a 2 and 20 fee structure on what is really large-scale growth equity can strip away the alpha; and why CMU is largely not active with multi-stage firms today. Miles also explains how he evaluates GPs, starting with whether they have their own cash in the fund, why it's nearly impossible to manage out AI exposure in any diversified portfolio, how secondaries work differently for seed funds and multi-stage firms, and why he believes true early-stage venture will always have a protected moat - and remains the innovation engine of the United States. Quotes “Are you putting your own cash into the fund? Which is, venture as an asset class seems pretty allergic to that concept. Would it hurt for you if this fund didn't do well? Would you experience the pain that we do, or are you just getting a free call option on our money? And if it hits, you win. If it doesn't, you've collected $30 million in management fees.” “Venture has changed as an asset class from its scale perspective so drastically over a short period of time that it's very hard to look at those returns from 10 years ago and then pattern match that to ‘we're gonna expect those returns today.’ That's the really hard part of an LP job.” Time Stamps [01:02] Meet Miles Dieffenbach: From the Steelers to the CMU Endowment [04:58] Points on the Scoreboard: Can You Hide in Venture? [07:53] Why Venture's Beta Will Be Worse Going Forward [10:07] How CMU Picks: Fat Right Tails and Entry Ownership Math [10:50] The Anthropic Math: Why a Huge Outcome Won't Return a Mega Fund [12:28] Underwriting to a 4X Net: The Public Market Benchmark [13:56] Are LPs Subsidizing Bad Returns? [16:30] 2 and 20 on the Qs: How Fees Strip Away the Alpha [17:31] Long Feedback Loops and How AI Saved the Day [19:09] Why Sovereign Wealth Funds Still Pay the Fees [21:06] Missionaries vs. Mercenaries: Finding Great Pickers in AI [22:25] GP Commitment and the Free Call Option [23:42] Why CMU Won't Back a Manager for Just a Fund or Two [25:41] When CMU Doesn't Re-Up [26:46] Bigger Exits, but Not $20 Trillion IPOs [27:39] Nowhere to Run: Managing AI Exposure at the Endowment Level [30:34] Can Venture Be Bubbly While Public Markets Reprice Risk? [32:32] Secondaries: Seed Funds vs. Multi-Stage Firms [34:31] Liquidity, Opportunity Funds, and Conflicts of Interest [37:02] Why Early-Stage Venture Still Has a Moat [39:14] Venture as America's Innovation Engine Links Connect with the guest and hosts on LinkedIn! Miles Dieffenbach Nick Chirls Beezer Clarkson Learn more about: Carnegie Mellon University Investment Office Dan Levine's post on venture's declining return targets LGT Capital Partners Asylum Ventures OpenLP
41 MIN
SEP 21, 2026
Robinhood's Sarah Pinto: Bringing Private Markets to the Public
What happens when you take the most exclusive asset class in the world and list it on the New York Stock Exchange? Sarah Pinto is finding out in public, every trading day. Sarah spent close to a decade investing in mission-driven growth-stage companies at Emerson Collective, the organization founded and led by Laurene Powell Jobs, where she helped build the venture effort and backed names that are now household ones: OpenAI, Anthropic, and Coinbase. She began investing in July of 2008, which turned out to be an instructive moment to start, and has been focused on tech since 2010. Today she is a portfolio manager at Robinhood Ventures, where she runs two funds built around a structural problem rather than an appetite one: only about 1% of Americans have any exposure to private companies, because most people aren’t accredited. Robinhood Ventures Fund I (RVI) is a ’40 Act closed-end fund that IPO’d in March 2026 and holds a concentrated portfolio of late-stage frontier companies: Databricks, OpenAI, Stripe, and SpaceX among them. Fund II (RVII) is the other side of the barbell: a BDC investing in a broad, diversified portfolio of Y Combinator seed-stage companies. Beezer digs into the machinery and the tensions - why the ’40 Act and BDC wrappers make any of this possible, how she pitches founders against Sequoia and Index, whether venture really belongs in a public product at all, and what the data actually shows about how retail investors behave when the price drops. It is a conversation about access, structure, and the strange discipline of running a venture portfolio in full public view. Quotes “Only about 1% of Americans have any exposure to privates, because most people aren’t accredited. Which means that they can only watch companies like Anthropic or OpenAI emerge from the sidelines. They can’t be a part of it. They can’t actually benefit from that value creation.” “Most of my GP equivalents at other funds don’t have to be marked to market every single day, whereas I am. That is the challenge. It comes with a lot of additional scrutiny and it comes with volatility that you don’t have if you are private. But it is the only way today that the SEC will let non-accredited investors invest - and frankly for good reasons.” “The CFOs of the companies we invest in know that retail is 25% to 30% of the stock market. In the same way that you bring crossover institutional investors into your late rounds, you should probably bring retail as a constituency. It’s the one constituency you don’t talk to until your IPO. And now you really need them.” Time Stamps [01:05] Meet Sarah Pinto: Emerson Collective to Robinhood Ventures [03:58] The Through Line: Investing at the Intersection of Purpose and Returns [05:46] Why Only 1% of Americans Can Access the Private Markets [07:10] What Emerson Collective Was Built to Do [08:15] RVI and the '40 Act Innovation: A Venture Fund That Trades Like an ETF [09:49] Robinhood as Both Distribution and Product [11:29] How the Portfolio Actually Gets Built [14:02] What You're Really Diligencing When You Buy the Fund [14:33] Why the Apple IPO Math Doesn't Work Anymore [15:44] Marked to Market Every Single Day [16:44] What Changes When You Manage Venture Publicly [19:38] The Pitch to Founders: Why Robinhood Is an N of One [21:35] Retail as a Constituency Before the IPO [23:58] Is Venture Really a Public Product? [24:19] Learn by Doing: Fees, Disclosure, and the $25 Share [28:01] RVII and the Other Side of the Barbell [29:48] Why YC: The Power Law, Concentration, and Hard Data [31:11] Taking a Seed Fund Through the LP Inquisition [31:59] The Live Roadshow and the Most Edgar Filings in IPO History [33:13] What's Next for Robinhood Ventures [36:30] Getting More Women Investing Early Links Connect with the guest and host on LinkedIn! Sarah Pinto Beezer Clarkson Learn more about: Robinhood Ventures Robinhood Ventures Fund I (RVI) Robinhood Ventures Fund II (RVII) Emerson Collective LGT Capital Partners OpenLP
38 MIN
AUG 20, 2026
Ask Forgiveness, Not Permission: Josh Browder on Building DoNotPay and Investing Like a Founder
What does it take to build a profitable company for a decade without ever really needing the money you raised? According to Joshua Browder, it comes down to one trait he looks for in every founder he backs: grit. Josh is the founder and CEO of DoNotPay, the consumer platform he started the summer before he enrolled at Stanford to help friends fight parking tickets. Nearly ten years later, DoNotPay has helped millions of people appeal tickets, cancel subscriptions, and fight companies and the government - and it's profitable enough that it pays dividends back to its own investors and team. Along the way, Josh raised from Andreessen Horowitz and Founders Fund, took the Thiel Fellowship (leaving Stanford one class short of his degree), and built a reputation as one of the more unconventional operators in consumer tech. Today, Josh also runs Browder Capital, a solo-GP pre-seed fund now on its fourth vehicle and backed by institutions including Sequoia. His model is deliberately narrow: one founder at a time, often moved into his own spare bedroom, with full access to his network until they raise an institutional seed round - then he moves on to the next. Nick and Josh get into the early days of DoNotPay - jailbreaking iPhones, an unauthorized Pret A Manger app that nearly got him sued at 14, and the Huffington Post post that took the company from 10 users to 50,000 in a week - and how that scrappy, bootstrapped era shaped the way he runs the company today. They also dig into DoNotPay's ongoing arms race with robocallers and big companies, why Josh thinks grit beats IQ when evaluating founders, how he tests for it in real time, and why - even as a full-time investor - he'd tell almost anyone to start a company before starting a fund. Time Stamps [02:27] Josh Browder's Origin Story: From London to Stanford [04:08] Jailbreaking iPhones, Selling Apps, and the Pret A Manger Cease-and-Desist [06:32] Coding DoNotPay the Summer Before Stanford and Going Viral Overnight [10:08] Nonprofit or For-Profit? A Cold DM From Marc Andreessen [11:30] Inside the Thiel Fellowship: Money, Peers, and Community [14:21] Going Solo, Sitting on Cash, and Finding a Business Model [15:00] Bootstrapping Then vs. Today's Mega Seed Rounds [17:55] Profitable, Dividend-Paying, and Barely Touching Its Capital [18:28] The Consumer Growth Playbook: Organic, SEO, and GEO [19:59] The Arms Race With Big Companies: DoNotPay's Robocaller Trap Card [24:04] How Browder Capital Started and the Owner.com Bet That Beat the Best VCs [25:29] The Model: One Founder, One Spare Bedroom, at a Time [30:54] Why Grit Beats IQ – and How Josh Tests for It [34:57] The Rise of "Ideological Fraud" in the Age of AI Deep Research [35:32] Lessons From Four Funds: Zero Reserves and Going Institutional [37:16] How Operator-GPs Won Over Institutional LPs [39:32] Final Advice: Start the Company, Not the Fund Links Connect with the guest and hosts on LinkedIn! Joshua Browder Beezer Clarkson Nick Chirls Learn more about: DoNotPay Browder Capital Asylum Ventures OpenLP Disclaimer: Opinions expressed by participants are their own and do not reflect the views of LGT Capital Partners, Asylum Ventures, DoNotPay, Browder Capital or its affiliates. The content does not take into account your specific investment objectives, financial situation, or needs, and is not intended as a recommendation, an offer, solicitation of an offer, public advertisement or recommendation to buy or sell any investment or other specific product. Information is based on sources believed to be reliable, but no warranty is given as to accuracy or completeness, and it should not be relied upon. Alternative investments are speculative, involve complex instruments, and carry a high degree of risk. Investments and strategies discussed may fluctuate in value and may not be suitable for all investors. Listeners should make their own independent investment decisions. No funds are being discussed on this podcast.
42 MIN